JAZZ vs PZZA · P/E 1988, rev $4.07B vs P/E 44, rev $2.06B
Jazz Pharmaceuticals PLC (JAZZ) versus Papa John's International Inc (PZZA) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Papa John's International Inc (PZZA) is a restaurants company listed on NASDAQ.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported PZZA revenue for 2024-12-29 was $2.06B. Net income was $84.2M. Revenue was down 3.6% from 2023-12-31 to 2024-12-29. PZZA currently screens at market cap $1.20B and trailing P/E 43.9.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. PZZA currently screens at market cap $1.20B and trailing P/E 43.9.
Not investment advice. Open the JAZZ and PZZA stock pages for the full models.
Not investment advice.